FDA Inspection 1258132 — Sanford Bismarck
The FDA completed an inspection of Sanford Bismarck on December 12, 2024 in Bismarck, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bismarck, ND (United States)